Work

Reply to: “COVID-19 vaccination in IMID patients receiving rituximab: A personalized regimen should be formulated”

Year: 2022

Type: letter

Source: Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2022.03.042

Authors: Vartan Pahalyants, William S. Murphy, Nikolai Klebanov, Chen Lu, Nicholas Theodosakis, Monina R. Klevens, Hossein Estiri, Evelyn Lilly, Maryam Asgari, Yevgeniy R. Semenov

Institutions: Brigham and Women's Hospital, Massachusetts General Hospital, Massachusetts Department of Public Health, Harvard University

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4220983183

Cites: 5

Cited by:

Related to: 10